(Q44443130)

English

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results (English)

1 reference

Europe PubMed Central

3 December 2017

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration (English)

1 reference

10.1016/S0161-6420(03)00085-X

https://api.crossref.org/works/10.1016/S0161-6420(03)00085-X

3 January 2024

0 references

neovascularization

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

fovea centralis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750101

3 January 2024

1 reference

10.1016/S0161-6420(03)00085-X

https://api.crossref.org/works/10.1016/S0161-6420(03)00085-X

3 January 2024

author name string

Eyetech Study Group

1

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12750101

3 January 2024

publication date

1 May 2003

1 reference

Europe PubMed Central

3 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S016164200300085X?httpAccept=text/xml

1 reference

10.1016/S0161-6420(03)00085-X

https://api.crossref.org/works/10.1016/S0161-6420(03)00085-X

3 January 2024

https://api.elsevier.com/content/article/PII:S016164200300085X?httpAccept=text/plain

1 reference

10.1016/S0161-6420(03)00085-X

https://api.crossref.org/works/10.1016/S0161-6420(03)00085-X

3 January 2024

1 reference

Europe PubMed Central

3 December 2017

110

1 reference

Europe PubMed Central

3 December 2017

979-986

1 reference

Europe PubMed Central

3 December 2017

5

1 reference

Europe PubMed Central

3 December 2017

Common causes of blindness and visual handicap in the west of Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of eye disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900085-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxygen-induced retinopathy in the mouse

15

1 reference

10.1016/S0161-6420(03)00085-X

https://api.crossref.org/works/10.1016/S0161-6420(03)00085-X

3 January 2024

Identifiers

10.1016/S0161-6420(03)00085-X

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44443130&oldid=2043816732"